I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...

Users on TikTok have touted the benefits of taking berberine supplements, claiming benefits for weight loss, heart health and ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland ...

Hims & Hers Health ( HIMS 6.30%) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth ...

Semaglutide, a diabetic injection ... The initiatives have helped the company record compound annual patient growth of 19% during FY22-24, against required growth of 14% CAGR to meet its target ...

Hundreds of law enforcement officials in South Korea have entered the residential compound of impeached President Yoon Suk Yeol in the capital Seoul, marking a dramatic escalation in the ...